Regeneron PharmaceuticalsREGN 
$714.47-0.09%24h
-0.09%24h
Global rank201
Market cap$76.54B
Change 7d-8.18%
YTD Performance-
SP500 benchmark
P/E0
P/S5.84
Revenue$13.12B
Earnings$3.95B
Dividend yield-
Main Sector
Healthcare
Regeneron Pharmaceuticals REGN Operating Margins
Operating Margin in 2022: 0.32%
According to Regeneron Pharmaceuticals latest financial reports the company has an operating margin of 0.32%, an decrease of -21.34% to 2022. At the end of 2022 company had an operating margin of 0.41%.
Regeneron Pharmaceuticals Operating Margin from 2020 to 2025
-
Value:-
REGN Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 0.32% | -21.34% |
| 2022 | 0.41% | -26.70% |
| 2021 | 0.56% | 32.96% |
| 2020 | 0.42% | - |
View the highest operating margin companies 
